ENvue Medical, Inc.
FEED
$0.82
-$0.01-1.47%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -19.51M | -17.56M | -6.14M | -7.65M | -4.99M |
| Total Depreciation and Amortization | 1.10M | 897.00K | 639.00K | 382.00K | 19.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.72M | 5.63M | -3.42M | -528.00K | 271.00K |
| Change in Net Operating Assets | 351.00K | 1.66M | 1.68M | 1.69M | 1.42M |
| Cash from Operations | -12.34M | -9.37M | -7.24M | -6.11M | -3.28M |
| Capital Expenditure | -72.00K | -60.00K | -37.00K | -9.00K | -7.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 148.00K | 148.00K | 148.00K | 148.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -72.00K | 88.00K | 111.00K | 139.00K | 141.00K |
| Total Debt Issued | 610.00K | 1.66M | 3.66M | 360.00K | 1.05M |
| Total Debt Repaid | -3.08M | -3.08M | -3.08M | -2.08M | -- |
| Issuance of Common Stock | 23.09M | 19.19M | 17.24M | 1.40M | 28.00K |
| Repurchase of Common Stock | -- | -- | -- | -27.00K | -27.00K |
| Issuance of Preferred Stock | 8.22M | 8.22M | 8.22M | 8.22M | -- |
| Repurchase of Preferred Stock | -14.78M | -13.22M | -13.22M | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 12.00K | 12.00K | -- | -- | -- |
| Cash from Financing | 14.08M | 12.79M | 12.82M | 7.87M | 1.05M |
| Foreign Exchange rate Adjustments | 1.00K | 0.00 | -12.00K | -12.00K | -11.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.66M | 3.50M | 5.68M | 1.89M | -2.10M |